Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome Diagnostics Laboratory, |
RCV002276558 | SCV002565693 | pathogenic | Ehlers-Danlos syndrome | 2021-11-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000018731 | SCV004295614 | pathogenic | Ehlers-Danlos syndrome, classic type, 1 | 2023-06-25 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 17191). This premature translational stop signal has been observed in individual(s) with Ehlers-Danlos syndrome (PMID: 10777716, 31829210). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg792*) in the COL5A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL5A1 are known to be pathogenic (PMID: 23587214). |
OMIM | RCV000018731 | SCV000039014 | pathogenic | Ehlers-Danlos syndrome, classic type, 1 | 2000-06-01 | no assertion criteria provided | literature only |